Sponsor

Abramson Cancer Center at Penn Medicine

Clinical research sponsor

Published trials154
Recruiting shown22
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)NCT07454499 · lead sponsor · 2026-05-13
RECRUITING
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical TrialsNCT07040891 · lead sponsor · 2026-02-01
RECRUITING
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer SurvivorshipNCT07655934 · lead sponsor · 2026-01-20
RECRUITING
Safe and Explainable AINCT06694181 · lead sponsor · 2025-11-29
RECRUITING
Telehealth Collaborative Care Model (CoCM) in Lung CancerNCT07102147 · lead sponsor · 2025-08-18
RECRUITING
Hypofractionated WPPT With HDR BoostNCT06591819 · lead sponsor · 2025-01-15
RECRUITING
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerNCT06551116 · lead sponsor · 2024-10-10
RECRUITING
Integrating Telehealth to Advance Lung Cancer ScreeningNCT06638554 · lead sponsor · 2024-07-09
RECRUITING
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulESNCT05968898 · lead sponsor · 2024-01-09
RECRUITING
Prostate Tissue BioBankNCT06659614 · lead sponsor · 2024-01-01
RECRUITING
FES BPET-DBT in Newly Diagnosed Breast CancerNCT05659797 · lead sponsor · 2023-10-02
RECRUITING
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based TherapyNCT04691817 · lead sponsor · 2023-07-25
RECRUITING
FTT PET/CT in Metastatic Prostate CancerNCT05242744 · lead sponsor · 2023-03-01
RECRUITING
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)NCT03760575 · lead sponsor · 2023-01-10
RECRUITING
Role of the Immune Environment in Response to Therapy in Breast CancerNCT05396612 · lead sponsor · 2022-10-03
RECRUITING
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast CancerNCT04523857 · lead sponsor · 2021-11-01
RECRUITING
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerNCT04841148 · lead sponsor · 2021-06-01
RECRUITING
CTNNA1 Familial Expansion StudyNCT05126290 · lead sponsor · 2021-03-16
RECRUITING
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab MaintenanceNCT04332367 · lead sponsor · 2020-08-01
RECRUITING
[18F] F-GLN by PET/CT in Breast CancerNCT03863457 · lead sponsor · 2019-04-05
RECRUITING
Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung CancerNCT03546829 · lead sponsor · 2019-03-05
RECRUITING
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerNCT02732171 · lead sponsor · 2016-04-01
RECRUITING
Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric PatientsNCT07658768 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in OncologyNCT06955468 · lead sponsor · 2025-07-21
COMPLETED
Increasing Screening for Cancer Using EHR-Nudges ReplicationNCT06995703 · lead sponsor · 2025-06-02
COMPLETED
Effects of Immune Checkpoint Inhibitors on Coronary MicrovasculatureNCT06332131 · lead sponsor · 2025-01-15
ACTIVE_NOT_RECRUITING
Community Support Program for Lung Cancer Screening Volume IINCT06628167 · lead sponsor · 2024-10-01
COMPLETED
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast CancerNCT06019988 · lead sponsor · 2024-03-11
ACTIVE_NOT_RECRUITING
Hypertension and Arrhythmias in CLL Patients Treated With BTK InhibitorsNCT06211413 · lead sponsor · 2024-02-07
ENROLLING_BY_INVITATION
Increasing Screening for Cancer Using EHR-NudgesNCT06177795 · lead sponsor · 2023-12-18
COMPLETED
A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science ResearchNCT05852860 · lead sponsor · 2023-12-01
ENROLLING_BY_INVITATION
Increasing Adherence to Lung Cancer ScreeningNCT05832008 · lead sponsor · 2023-10-18
COMPLETED
Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense BreastsNCT05787249 · lead sponsor · 2023-10-04
COMPLETED
Behavioral Relaxation Approaches for Insomnia in Lung Cancer PatientsNCT04318249 · lead sponsor · 2023-09-30
WITHDRAWN
Lung Cancer Screening Eligibility AssessmentNCT06133816 · lead sponsor · 2023-07-31
COMPLETED
ChatBot and Activity Monitoring in Patients Undergoing ChemoradiotherapyNCT05318027 · lead sponsor · 2023-05-22
ACTIVE_NOT_RECRUITING
Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung CancerNCT05790460 · lead sponsor · 2023-05-08
TERMINATED
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer PredispositionNCT05721326 · lead sponsor · 2023-05-01
COMPLETED
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer PatientsNCT05226078 · lead sponsor · 2023-03-01
ACTIVE_NOT_RECRUITING
Community Support Program for Lung Cancer ScreeningNCT06207435 · lead sponsor · 2023-02-10
COMPLETED
Project PLUS Lung Cancer Screening PromotionNCT05937399 · lead sponsor · 2022-12-02
COMPLETED
RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)NCT05176756 · lead sponsor · 2022-04-14
COMPLETED
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerNCT05096338 · lead sponsor · 2021-10-27
ACTIVE_NOT_RECRUITING
Breast Cancer Outreach Among Primary Care PatientsNCT05089903 · lead sponsor · 2021-10-25
COMPLETED
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast CancerNCT05078190 · lead sponsor · 2021-10-21
ACTIVE_NOT_RECRUITING
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense BreastsNCT04854304 · lead sponsor · 2021-09-23
ACTIVE_NOT_RECRUITING
Telehealth Weight Loss Program for Breast Cancer SurvivorsNCT04855552 · lead sponsor · 2021-07-19
ACTIVE_NOT_RECRUITING
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer ScreeningNCT04798664 · lead sponsor · 2021-05-17
COMPLETED
BAPS in Botswana: The Thotloetso TrialNCT04532970 · lead sponsor · 2021-05-06
COMPLETED
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerNCT04735068 · lead sponsor · 2021-04-09
COMPLETED
Pilot Study of an NTproBNP Guided Strategy of CardioprotectionNCT04737265 · lead sponsor · 2021-03-18
COMPLETED
Implementation Strategies for Monitoring Adherence in Real TimeNCT04347161 · lead sponsor · 2021-02-22
ACTIVE_NOT_RECRUITING
India HIV-CervCa ProjectNCT07167069 · lead sponsor · 2021-02-09
COMPLETED
Functional Lung Imaging With DECT and 4DCTNCT04702607 · lead sponsor · 2021-01-02
COMPLETED
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade TherapyNCT04454528 · lead sponsor · 2020-12-07
ACTIVE_NOT_RECRUITING
PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI CancersNCT04616768 · lead sponsor · 2020-11-19
COMPLETED
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair DefectsNCT04288687 · lead sponsor · 2020-10-19
COMPLETED
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast CancerNCT03685331 · lead sponsor · 2020-10-15
COMPLETED
The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer PatientsNCT06604247 · lead sponsor · 2020-09-30
COMPLETED
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation TherapyNCT04305613 · lead sponsor · 2020-09-14
ACTIVE_NOT_RECRUITING

Sponsor roles

lead sponsor152
collaborator2

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.